Breast Cancer
Articles and resources on breast cancer for patients, caregivers, and family members
The new cancer drug Tukysa (tucatinib), when given in combination with Herceptin (trastuzumab) and capecitabine, dramatically improved outcomes for patients with HER2-positive advanced breast cancer that has spread to the brain, according to data presented by Nancy U. Lin, MD, Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, at the 2020 ASCO annual meeting. Read More ›
Metastatic breast cancer is cancer that has spread beyond the breast to other parts of the body. Visceral metastases refer to cancer that has spread to the internal organs of the body, specifically those within the chest (such as the heart or lungs) or abdomen (such as the liver, pancreas, or intestines). Read More ›
By Chase Doyle
Induction treatment with endocrine and targeted therapies has significantly improved survival for patients with hormone receptor (HR)-positive advanced breast cancer, but over time almost all patients stop responding to therapy. Read More ›
In April, 2020, the FDA approved Trodelvy for the treatment of adults with metastatic triple-negative breast cancer after 2 or more previous therapies. Read More ›
By Kelsey Moroz
With her family history of cancers related to the BRCA mutation, Jamie Ledezma’s first pregnancy suddenly got very complicated when she learned she had triple-negative breast cancer. Read More ›
We are all now living in the land of uncertainty, and many patients with cancer have had their treatment plans interrupted. Breast cancer survivor and CONQUER magazine’s Editor-in-Chief Lillie E. Shockney looks at how COVID-19 may affect patients dealing with cancer these days. Read More ›
An encouraging story of survival from a breast cancer nurse navigator who is also a breast cancer survivor. Read More ›
Your nurse navigator will be with you through each phase of your treatment. Start your relationship by asking these questions. Read More ›
By Dana Taylor
Breast cancer is the second
most common cancer
among women, but it
is important to remember
that men can also have breast
cancer. Recent advances in
therapy have led to the discovery
of specific biologic markers
(biomarkers) in cancer cells,
which has further led to the development
of drugs known as
targeted therapies. Read More ›
Another drug approved by the FDA in April, Tukysa, a kinase inhibitor, is a new treatment option for the treatment of patients with advanced HER2-positive breast cancer. Read More ›